Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam long-term follow-up in partial seizures
NCT03250377Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2017
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of brivaracetam in focal seizures, sponsored by UCB. Started Aug 2017; status: completed.
02
Drugs
brivaracetam
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT03250377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250377.